deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT03003065

Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers (PDT)

Safety and Tumoricidal Effect of Low Dose Temoporfin Photodynamic Therapy in Patients With Inoperable Bile Duct Cancers (Foscan® Study)

Sponsor: Chinese University of Hong Kong

Conditions Cholangiocarcinoma Klatskin Tumor Tumor
Interventions Temoporfin
Updated 13 times since 2017 Last updated: Aug 20, 2023 Started: Mar 28, 2014 Primary completion: Apr 12, 2023 Completion: Aug 12, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03003065, this PHASE2 trial focuses on Cholangiocarcinoma and Klatskin Tumor and remains completed. Sponsored by Chinese University of Hong Kong, it has been updated 13 times since 2014, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Nov 2019 · 15 months · monthly snapshot~Nov 2019 – ~Oct 2020 · 11 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Apr 2022 · 14 months · monthly snapshot~Apr 2022 – ~Sep 2023 · 17 months · monthly snapshot~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Sep 2023 — Jul 2024 [monthly]

    Completed PHASE2

    Status: Recruiting → Completed

  4. Apr 2022 — Sep 2023 [monthly]

    Recruiting PHASE2

  5. Feb 2021 — Apr 2022 [monthly]

    Recruiting PHASE2

▶ Show 8 earlier versions

  1. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE2

  2. Oct 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  3. Nov 2019 — Oct 2020 [monthly]

    Recruiting PHASE2

  4. Aug 2018 — Nov 2019 [monthly]

    Recruiting PHASE2

  5. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE2

  6. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE2

  7. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  8. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chinese University of Hong Kong
Data source: Chinese University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations